Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis

被引:44
|
作者
Sakai, K [1 ]
Busby, WH [1 ]
Clarke, JB [1 ]
Clemmons, DR [1 ]
机构
[1] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA
关键词
D O I
10.1074/jbc.M008359200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Insulin-like growth factor-binding protein-1 (IG-FBP-1) binds to insulin-like growth factors (IGFs) and has been shown to inhibit or stimulate cellular responses to IGF-I in vitro. This capacity of IGFBP-1 to inhibit or stimulate IGF-I actions correlates with its ability to form stable high molecular weight multimers, Since the ability of some proteins to polymerize is dependent upon transglutamination, we determined if tissue transglutaminase could catalyze this reaction and the effect of polymerization of IGFBP-1 upon IGF-I action, Following incubation with pure tissue transglutaminase (Tg), IGFBP-1 formed covalently linked multimers that were stable during SDS-polyacrylamide gel electrophoresis using reducing conditions. Dephosphorylated IGFBP-1 polymerized more rapidly and to a greater extent compared with native (phosphorylated) IGFBP-1. Exposure to IGF-I stimulated transglutamination of IGFBP-1 in vitro. An IGFBP-1 mutant in which Gln(66)-Gln(67) had been altered to Ala(66)-Ala(67) (Q66A/Q67A) was relatively resistant to polymerization by Tg compared with native IGFBP-1. Tg localized in fibroblast membranes was also shown to catalyze the formation of native IGFBP-1 multimers, however, Q66A/Q67A IG-FBP-1 failed to polymerize. Although the mutant IG-FBP-1 potently inhibited IGF-I stimulated protein synthesis in pSMC cultures, the same concentration of native IGFBP-1 had no inhibitory effect. The addition of higher concentrations of native IGFBP-1 did inhibit the protein synthesis response, and this degree of inhibition correlated with the amount of monomeric IGFBP-1 that was present. In conclusion, IGFBP-1 is a substrate for tissue transglutaminase and Tg leads to the formation of high molecular weight covalently linked multimers. Polymerization is an important post-translational modification of IGFBP-1 that regulates cellular responses to IGF-I.
引用
收藏
页码:8740 / 8745
页数:6
相关论文
共 50 条
  • [21] Cloning and regulation of the baboon insulin-like growth factor binding protein-1 (IGFBP-1) promoter.
    Kim, JJ
    Jaffe, RC
    Unterman, T
    Fazleabas, AT
    BIOLOGY OF REPRODUCTION, 2001, 64 : 328 - 328
  • [22] Calpain proteolysis of insulin-like growth factor binding protein (IGFBP)-2 and-3, but not of IGFBP-1
    Berg, Ulrika
    Bang, Peter
    Carlsson-Skwirut, Christine
    BIOLOGICAL CHEMISTRY, 2007, 388 (08) : 859 - 863
  • [23] REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN (IGFBP) GENE-EXPRESSION - TISSUE-SPECIFIC EXPRESSION OF IGFBP-1
    GROYER, A
    BABAJKO, S
    HARDOUIN, S
    LENEUVE, P
    BINOUX, M
    ANNALES D ENDOCRINOLOGIE, 1991, 52 (06) : 447 - 450
  • [24] Insulin-like growth factor-binding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation
    Kajimura, S
    Aida, K
    Duan, CM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (04) : 1240 - 1245
  • [25] THE CONCENTRATIONS OF INSULIN-LIKE GROWTH FACTOR-I (IGF-I) AND INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-1 (IGFBP-1) IN HUMAN MATERNAL AND UMBILICAL-CORD SERUM
    WANG, HS
    LIM, J
    ENGLISH, J
    IRVINE, L
    CHARD, T
    JOURNAL OF PHYSIOLOGY-LONDON, 1991, 438 : P235 - P235
  • [26] High Serum Insulin-Like Growth Factor-Binding Protein 1 (IGFBP-1) is Associated with High Fracture Risk Independent of Insulin-Like Growth Factor 1 (IGF-I)
    Hans Lundin
    Maria Sääf
    Lars-Erik Strender
    Sven Nyren
    Sven-Erik Johansson
    Helena Salminen
    Calcified Tissue International, 2016, 99 : 333 - 339
  • [27] REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN (IGFBP) EXPRESSION BY BREAST-CANCER CELLS - USE OF IGFBP-1 AS AN INHIBITOR OF INSULIN-LIKE GROWTH-FACTOR ACTION
    MCGUIRE, WL
    JACKSON, JG
    FIGUEROA, JA
    SHIMASAKI, S
    POWELL, DR
    YEE, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (17) : 1336 - 1341
  • [28] High Serum Insulin-Like Growth Factor-Binding Protein 1 (IGFBP-1) is Associated with High Fracture Risk Independent of Insulin-Like Growth Factor 1 (IGF-I)
    Lundin, Hans
    Saaf, Maria
    Strender, Lars-Erik
    Nyren, Sven
    Johansson, Sven-Erik
    Salminen, Helena
    CALCIFIED TISSUE INTERNATIONAL, 2016, 99 (04) : 333 - 339
  • [29] Insulin-like growth factor protein test (IGFBP-1) in predicting preterm delivery
    Paternoster, D
    Pignatara, R
    Grella, P
    LABOR AND DELIVERY, 1998, : 375 - 378
  • [30] Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke
    Kaplan, Robert C.
    McGinn, Aileen P.
    Pollak, Michael N.
    Kuller, Lewis H.
    Strickler, Howard D.
    Rohan, Tom E.
    Cappola, Anne R.
    Xue, XiaoNan
    Psaty, Bruce M.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1319 - 1325